Health on MSN6 天
What's the Difference Between Asthma and Chronic Obstructive Pulmonary Disease (COPD)?
Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...
Simple breathing trick can help calm terrifying symptoms of chronic condition
Experts share their tips for breathing easier - even if you have a chronic condition such as asthma or chronic obstructive ...
Early Signs of COPD Found Through Nasal Inflammation
Researchers at Karolinska Institutet have now shown that material from nasal lavage provides a basis for assessing COPD. The ...
Medindia3 天
Nasal Proteins Provide Vital Clues for Early COPD Diagnosis
Elevated IL-26 levels in the nose of smokers with and without COPD may provide a simple method for early detection and ...
AlphaGalileo6 天
Protein in the nose provides information about COPD
Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Medical Xpress6 天
Adverse outcomes increased with long-term inhaled corticosteroids in COPD
Wilson D. Pace, M.D., from DARTNet Institute in Aurora, Colorado, and colleagues examined electronic health record data for individuals older than 45 years with COPD to assess long-term ICS risks ...
Pharmabiz8 天
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
Medical Dialogues4 天
Sanofi Dupixent approved in Japan for COPD
Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...